Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes
Aims The aim of the present study was to identify characteristics in women diagnosed with gestational diabetes mellitus (GDM) that could be predictive of congenital malformations in their infants. Methods Using data from the Spanish Collaborative Study of Congenital Malformations (ECEMC), a hospit...
Saved in:
Published in: | Diabetic medicine Vol. 22; no. 6; pp. 775 - 781 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Science Ltd
01-06-2005
Blackwell |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims The aim of the present study was to identify characteristics in women diagnosed with gestational diabetes mellitus (GDM) that could be predictive of congenital malformations in their infants.
Methods Using data from the Spanish Collaborative Study of Congenital Malformations (ECEMC), a hospital‐based case‐control study and surveillance system, we assessed the relationship between a number of maternal variables, including pre‐gestational body mass index (BMI), and specific congenital malformations in their infants.
Results The overall risk for a selected group of congenital malformations in an infant of an obese mother with GDM compared with an obese mother with normal glucose tolerance (NGT) was 2.78 (1.38–5.55, P < 0.001). Within the group of mothers with GDM, obesity (BMI ≥ 30 kg/m2) was associated with a significantly increased risk of cardiovascular defects compared with non‐obese women [OR = 2.82 (1.31–7.04), P < 0.01]. In mothers with NGT, pre‐gestational BMI was not associated with congenital malformations.
Conclusion Pre‐gestational obesity is a predictive variable for congenital malformations in infants of mothers with GDM. The greater their BMI, the higher the risk for congenital malformations in their offspring. Given the blastogenic origin of the congenital defects identified, and the relationship between obesity and Type 2 diabetes, it is probable that this increased risk is as a result of previously unidentified pre‐gestational diabetes mellitus (PGD). It is important that overweight and obese women planning a pregnancy be evaluated for the presence of diabetes. |
---|---|
Bibliography: | istex:6B1EBC5A1F5EA6D020B9526B9E33A78ECD437D82 ArticleID:DME1492 ark:/67375/WNG-FLSQ4W84-H ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0742-3071 1464-5491 |
DOI: | 10.1111/j.1464-5491.2005.01492.x |